Skip to main content

Want a detailed portfolio tracker?

Advanced Biomed (ADVB) Total Assets (2023 - 2026)

Advanced Biomed (ADVB) total assets from Jun 30, 2023 to Mar 31, 2026. The current Advanced Biomed (ADVB) total assets is $11M. You can adjust inflation or export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Total Assets

Total Assets

Advanced Biomed (ADVB) Total Assets CAGR table

PeriodCAGR
1 Year TTM+140.35%
All Time TTM+257.66%

Annual Total Assets change of Advanced Biomed (ADVB)

YearTotal AssetsChange
2025$6.51M
+45.96%
2024$4.46M
N/A
2023$0
N/A

Comparison Advanced Biomed (ADVB) total assets with competitors

Advanced Biomed (ADVB) total assets is $10.65M.

TickerNameTotal AssetsUpside
TMOThermo Fisher Scientific Inc$113.28B+1063571.36%
DHRDanaher Corp$83.54B+784350.70%
IQVIQVIA Holdings Inc$29.68B+278538.50%
WATWaters Corp$24.53B+230238.03%
LHLaboratory Corp Of America Holdings$19.09B+179121.60%
DGXQuest Diagnostics Inc$16.67B+156453.99%
ICLRIcon Plc$16.27B+152667.91%
AAgilent Technologies Inc$13.06B+122576.06%
RVTYRevvity Inc$12.00B+112544.04%
CRLCharles River Laboratories International Inc$7.73B+72485.05%
ILMNIllumina Inc$6.56B+61486.85%
QGENQiagen NV$6.28B+58878.70%
EXASExact Sciences Corp$5.86B+54929.38%
RDNTRadnet Inc$3.89B+36382.53%
MTDMettler-Toledo International Inc$3.67B+34349.91%
IDXXIdexx Laboratories Inc$3.39B+31688.70%
SHCSotera Health Company$3.24B+30284.02%
GRALGRAIL Inc$2.80B+26223.70%
NTRANatera Inc$2.61B+24448.34%
MEDPMedpace Holdings Inc$2.13B+19896.37%
GHGuardant Health Inc$1.92B+17883.95%
OPKOpko Health Inc$1.86B+17334.70%
VCYTVeracyte Inc$1.44B+13387.32%
NEONeogenomics Inc$1.36B+12668.36%
FLGTFulgent Genetics Inc$1.16B+10757.92%
BNRBurning Rock Biotech Ltd$885.30M+8212.72%
NOTVInotiv, Inc. Common Stock$702.42M+6495.47%
BLLNBilliontoone Inc - Class A$700.73M+6479.60%
TWSTTwist Bioscience Corp$676.21M+6249.43%
MYGNMyriad Genetics Inc$673.70M+6225.82%
CSTLCastle Biosciences Inc$547.80M+5043.71%
WGSGeneDx Holdings Corp - Class A$506.30M+4654.00%
ADPTAdaptive Biotechnologies Corp$505.94M+4650.64%
CDNACaredx Inc$411.06M+3759.74%
PSNLPersonalis Inc$325.39M+2955.35%
FONRFonar Corp$219.22M+1958.42%
MDXHMDxHealth SA$147.95M+1289.23%
BDSXBiodesix Inc$94.64M+788.61%
PRPHProPhase Labs Inc$65.70M+516.92%
XGNExagen Inc$51.96M+387.86%
IMDXInsight Molecular Diagnostics Inc$40.43M+279.60%
XWELXWELL Inc$24.99M+134.67%
PRPOPrecipio Inc$20.80M+95.33%
APDNApplied Dna Sciences Inc$9.93M-6.72%
ISPCiSpecimen Inc$9.53M-10.50%
BIAFBioAffinity Technologies Inc$7.95M-25.40%
MYNZMainz Biomed N.V.$7.72M-27.53%
MBAICheckCap Ltd$7.49M-29.71%
NDRAENDRA Life Sciences Inc$3.44M-67.72%
CHEKCheck-Cap Ltd$377000.00-96.46%